Company Overview
Snapshot
Founded in January 2020 by Valery Diamant, Marat Lerner, and Gideon Meiry, NTMed operates with 1–10 employees. The company has raised $800K across one funding round, focusing on developing advanced wound healing solutions.
Business overview
NTMed is a Health Tech & Life Sciences company specializing in the development of novel materials for chronic wound healing. The company's core technology integrates electrical exogenous stimulus with antimicrobial efficacy to enhance regenerative processes. NTMed targets the pharmaceutical and healthcare industries, addressing the significant costs and challenges associated with non-healing wounds, such as surgical wounds and diabetic ulcers.
Log in to access full profile ›Company Intelligence Q&A
- When was NTMed founded?
- NTMed was founded in January 2020 by Valery Diamant, Marat Lerner, and Gideon Meiry.
- What is NTMed's primary focus?
- NTMed focuses on developing advanced materials that combine electrical exogenous stimulus with antimicrobial efficacy to enhance wound healing processes.
- What problem does NTMed aim to solve?
- NTMed aims to address the challenges and high costs associated with chronic, non-healing wounds, including surgical wounds and diabetic ulcers, by developing more effective healing solutions.
- What is the status of NTMed's product development?
- NTMed's product development is currently in the R&D stage, focusing on novel materials that combine electrical exogenous stimulus with antimicrobial efficacy for enhanced healing.
- What is NTMed's business model?
- NTMed operates on a B2B2C business model.